These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 4127420)
1. [Progesterone drugs and adenoma of the prostate. Considerations on a 4-year trial]. Steckelmacher P Acta Urol Belg; 1973 Jul; 41(3):462-4. PubMed ID: 4127420 [No Abstract] [Full Text] [Related]
2. Gestronol hexanoate (SH582) and benign prostatic hypertrophy. Pitchford AG Proc R Soc Med; 1972 Feb; 65(2):128-9. PubMed ID: 4117436 [No Abstract] [Full Text] [Related]
3. [Use of progesterone in prostatic adenoma]. Shcherbakov AP Urol Nefrol (Mosk); 1978; (1):72-6. PubMed ID: 75603 [No Abstract] [Full Text] [Related]
4. [On the treatment of prostatic adenoma with hydroxyprogesterone caronate]. Ibba AL Osp Ital Chir; 1968; 19(4):427-42. PubMed ID: 4180617 [No Abstract] [Full Text] [Related]
5. [Results and considerations on several cases of prostatic hypertrophy treated with hydroxyprogesterone capronate]. Tinunin O Minerva Urol; 1969; 21(4):107-20. PubMed ID: 4192306 [No Abstract] [Full Text] [Related]
6. [On medical therapy of prostate hypertrophy with a synthetic progestational hormone. (Preliminary note)]. Frizzi V Minerva Med; 1970 Feb; 61(15):694-9. PubMed ID: 4190508 [No Abstract] [Full Text] [Related]
7. [Clinical and cysto-sphincterometric results of progestogen therapy of prostatic adenoma]. Makrigiannis D; Gaca AH Clin Ter; 1971 Jun; 57(5):399-416. PubMed ID: 4107104 [No Abstract] [Full Text] [Related]
8. [Studies using synthetic progestogens in drug therapy of so-called prostatic hypertrophy]. Scultéty S; Sas M; Varga B Z Urol Nephrol; 1973 Jan; 66(1):49-59. PubMed ID: 4121364 [No Abstract] [Full Text] [Related]
12. [Treatment of hypertrophy of the prostate with gestagens]. Vahlensieck W; Gödde S Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927 [No Abstract] [Full Text] [Related]
13. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse. Caine M; Superstine E Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461 [No Abstract] [Full Text] [Related]
14. [Animal experimental studies using 19-nor-17 alpha-hydroxyprogesterone caproate (Gestenoroncapronat) with respect to a possible therapeutic application in prostatic adenoma]. Hahn JD; Neumann F; Berswordt-Wallrabe R Urologe; 1968; 7(4):208-14. PubMed ID: 4177764 [No Abstract] [Full Text] [Related]
15. [Current possibilities in the treatment of prostatic adenoma]. Grims P; Bemarić R Lijec Vjesn; 1974 Dec; 96(12):B786-9. PubMed ID: 4142059 [No Abstract] [Full Text] [Related]
16. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate]. Nagel R; Hargenda B Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356 [No Abstract] [Full Text] [Related]
17. Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate. Scott WW; Wade JC J Urol; 1969 Jan; 101(1):81-5. PubMed ID: 4178189 [No Abstract] [Full Text] [Related]
18. Evaluation of hydroxyprogesterone caproate in the treatment of benign prostatic hyperplasia. Jacobs D; Harper JM; Politano VA South Med J; 1967 Nov; 60(11):1174-6. PubMed ID: 4168673 [No Abstract] [Full Text] [Related]
19. Nonoperative management of senile prostatic hyperplasia. Fam A Int Surg; 1971 Oct; 56(4):252-9. PubMed ID: 4106484 [No Abstract] [Full Text] [Related]